A Multi-omics and Machine Learning Framework Identifies Plasma SBDS as a Causal Biomarker and Therapeutic Target in Primary Sclerosing Cholangitis

Pengfei Cheng, Yuanming Qiang, Yibo Sun, Binwei Duan, Yabo Ouyang, Guangming Li

Open source

DOI
10.14218/jcth.2025.00676
Published
2026-03-20
Container
Journal of Clinical and Translational Hepatology
Publisher
Xia & He Publishing
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.14218/jcth.2025.00676,
  title = {A Multi-omics and Machine Learning Framework Identifies Plasma SBDS as a Causal Biomarker and Therapeutic Target in Primary Sclerosing Cholangitis},
  author = {Pengfei Cheng and Yuanming Qiang and Yibo Sun and Binwei Duan and Yabo Ouyang and Guangming Li},
  year = {2026},
  journal = {Journal of Clinical and Translational Hepatology},
  doi = {10.14218/jcth.2025.00676},
  url = {https://doi.org/10.14218/jcth.2025.00676}
}

RIS

TY  - JOUR
TI  - A Multi-omics and Machine Learning Framework Identifies Plasma SBDS as a Causal Biomarker and Therapeutic Target in Primary Sclerosing Cholangitis
AU  - Pengfei Cheng
AU  - Yuanming Qiang
AU  - Yibo Sun
AU  - Binwei Duan
AU  - Yabo Ouyang
AU  - Guangming Li
PY  - 2026
JO  - Journal of Clinical and Translational Hepatology
DO  - 10.14218/jcth.2025.00676
UR  - https://doi.org/10.14218/jcth.2025.00676
ER  - 

APA

Cheng, P., Qiang, Y., Sun, Y., Duan, B., Ouyang, Y., & Li, G. (2026). A Multi-omics and Machine Learning Framework Identifies Plasma SBDS as a Causal Biomarker and Therapeutic Target in Primary Sclerosing Cholangitis. Journal of Clinical and Translational Hepatology. https://doi.org/10.14218/jcth.2025.00676

Source records